InvestorsHub Logo
Followers 62
Posts 7552
Boards Moderated 1
Alias Born 01/02/2003

Re: Bolio98 post# 405668

Monday, 03/13/2023 3:20:11 PM

Monday, March 13, 2023 3:20:11 PM

Post# of 426151
What makes this a NEW situation is that the generics are not using the patented capsule for their gV that Amarin uses for Vascepa...In a failing attempt to obviate the oxidation, which limits the effectiveness of the EPA(THE ACTIVE INGREDIENT WITHIN THE CAPSULE), the generics are using fillers ,which not only make the color, taste, and smell of their gV product, different from that of Vascepa, but these fillers are potentially harmful.

It is time to bring this festering situation to the attention of the FDA!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News